OH_Logo.png
Optimi Health Supports Patient-Focused Psilocybin Advocacy by TheraPsil
29 juin 2021 09h00 HE | Optimi Health Corp.
VANCOUVER, British Columbia, June 29, 2021 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a vertically integrated developer of mushroom...
OH_Logo.png
Optimi Health Engages U.S. Based Law Firm for Patent Support
23 juin 2021 09h00 HE | Optimi Health Corp.
VANCOUVER, British Columbia, June 23, 2021 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a vertically integrated developer of mushroom...
OH_Logo.png
Optimi Health Completes OTC Markets Uplisting to OTCQB
17 juin 2021 09h00 HE | Optimi Health Corp.
VANCOUVER, British Columbia, June 17, 2021 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a vertically integrated mushroom product...
OH_Logo.png
Optimi Health Completes Pre-Clinical Trial Application Meeting
15 juin 2021 09h00 HE | Optimi Health Corp.
VANCOUVER, British Columbia, June 15, 2021 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a vertically integrated mushroom product developer...
OH_Logo.png
Optimi Health Announces Product Distribution Agreement with Vitasave
08 juin 2021 09h00 HE | Optimi Health Corp.
VANCOUVER, British Columbia, June 08, 2021 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated functional...
OH_Logo.png
Optimi Health Announces DTC Eligibility & Up-List to OTCQB
03 juin 2021 09h00 HE | Optimi Health Corp.
VANCOUVER, British Columbia, June 03, 2021 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated functional...
OH_Logo.png
Optimi Health Appoints Chief Science Officer
26 mai 2021 09h00 HE | Optimi Health Corp.
VANCOUVER, British Columbia, May 26, 2021 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated functional...
OH_Logo.png
Optimi Health and Numinus Wellness Submit All-Natural Psilocybin Extract to Health Canada for Pre-Clinical Trial Application
11 mai 2021 09h00 HE | Optimi Health Corp.
VANCOUVER, British Columbia, May 11, 2021 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated functional...
OH_Logo.png
Optimi Health Partnership with Numinus Wellness Provides Update on First All-Natural Psilocybin Protocol
04 mai 2021 09h00 HE | Optimi Health Corp.
VANCOUVER, British Columbia, May 04, 2021 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated functional...
OH_Logo.png
Optimi Health Finalizes Planned Build-Out of Mushroom Production and Research Facility
27 avr. 2021 09h00 HE | Optimi Health Corp.
VANCOUVER, British Columbia, April 27, 2021 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated functional...